サンプル依頼リスト カート
  • English
  • Korean
表紙：視神経障害治療の世界市場レポート 2024年
市場調査レポート
商品コード
1415744

視神経障害治療の世界市場レポート 2024年

Optic Nerve Disorders Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
視神経障害治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

視神経障害治療市場規模は近年力強く成長しています。2023年の35億9,000万米ドルから2024年には38億1,000万米ドルに、CAGR6.0％で拡大します。実績期間の成長は、標的治療、遠隔医療の拡大、患者のエンパワーメント、世界の共同研究に起因しています。

高齢者人口の急増は、予測可能な将来において視神経障害治療市場拡大の原動力になると考えられています。この層には、通常65歳以上の高齢者が含まれます。この層では、視神経障害が視力障害の有力な原因となっています。視神経障害治療は、この高齢者層特有のニーズに対応する上で重要な役割を果たし、視力の向上、全体的な生活の質の改善、関連症状の緩和を目指しています。例えば、世界保健機関（WHO）が2022年10月に発表した報告書によると、2030年までに世界の6人に1人が60歳以上になると予測されています。さらに先の2050年には、世界の60歳以上の人口は21億人に達すると予想されています。さらに、80歳以上の高齢者の数は、2020年から2050年の間に、現在より4億2,600万人増加すると予測されています。したがって、高齢者人口の増加は視神経障害治療市場の成長を促進する極めて重要な要因となっています。

2023年の視神経障害治療市場で最大の地域は北米でした。視神経障害治療レポートがカバーしている地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の視神経障害治療市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の視神経障害治療市場規模実績と成長、2018～2023年
  • 世界の視神経障害治療市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の視神経障害治療市場、治療タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • ステロイド療法
  • 免疫調節療法
  • その他
  • 世界の視神経障害治療市場、適応症別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 緑内障
  • 視神経炎
  • 視神経症
  • 先天性視神経萎縮症
  • その他
  • 世界の視神経障害治療市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • 外来手術センター
  • クリニック
  • その他

第7章 地域と国の分析

  • 世界の視神経障害治療市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の視神経障害治療市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 視神経障害治療市場の競合情勢
  • 視神経障害治療市場の企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck and Co. Inc.
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.

第31章 その他の主要と革新的な企業

  • Alcon Inc.
  • Sun Pharmaceutical Industries Limited
  • Bausch + Lomb Corporation
  • Horizon Therapeutics Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Allergan Inc.
  • Akorn Inc.
  • Ionis Pharmaceuticals Inc.
  • Lumenis Ltd.
  • Glaukos Corporation
  • Nidek Co. Ltd.
  • Aerie Pharmaceuticals Inc.
  • Spark Therapeutics Inc.
  • IRIDEX Corporation
  • Kowa Company Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r12343

“Optic Nerve Disorders Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on optic nerve disorders treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for optic nerve disorders treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The optic nerve disorders treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Treatment Type: Steroidal Therapy; Immunomodulators therapy; Other Treatment Types
  • 2) By Indication: Glaucoma; Optic Neuritis; Optic Neuropathy; Congenital Optic Atrophy; Other Indications
  • 3) By End User: Hospitals; Ambulatory Surgery Centers; Clinics; Other End Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck and Co. Inc.; Novartis AG; Regeneron Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Optic nerve disorder treatment encompasses a range of medical interventions aimed at diagnosing, managing, and potentially improving or preserving the function of the optic nerve, which is responsible for transmitting visual information from the eye to the brain. This treatment addresses conditions where patterns of visual loss are brought on by inherited or acquired abnormalities of the optic nerves.

The primary types of treatment for optic nerve disorders include immunomodulator therapy, steroidal therapy, and other approaches. Immunomodulator therapy involves the use of medications that either enhance or suppress the immune response, thereby enabling the immune system to function more effectively. This form of treatment is indicated for conditions such as glaucoma, optic neuritis, optic neuropathy, congenital optic atrophy, among others. These treatments are administered across various healthcare settings including hospitals, ambulatory surgery centers, clinics, and other medical facilities.

The optic nerve disorder treatment market research report is one of a series of new reports from The Business Research Company that provides optic nerve disorder treatment market statistics, including optic nerve disorder treatment industry global market size, regional shares, competitors with an optic nerve disorder treatment market share, detailed optic nerve disorder treatment market segments, market trends and opportunities and any further data you may need to thrive in the optic nerve disorder treatment industry. This optic nerve disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The optic nerve disorders treatment market size has grown strongly in recent years. It will grow from $3.59 billion in 2023 to $3.81 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to targeted therapies, telemedicine expansion, patient empowerment, global collaborative research.

The optic nerve disorders treatment market size is expected to see strong growth in the next few years. It will grow to $4.67 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote procedures, patient education and awareness, reimbursement policies. Major trends in the forecast period include artificial vision and bionic eye devices, optic nerve regeneration, integration of ai in ophthalmology, community-based vision programs.

The surge in the prevalence of eye disorders is set to propel the expansion of the optic nerve disorder treatment market in the foreseeable future. Eye disorders encompass a range of illnesses or conditions that affect the various components and tissues of the eyes. Optic nerve disorder treatment plays a crucial role in aiding patients afflicted with eye disorders, particularly in treating conditions like glaucoma by either slowing down or preventing further damage to the optic nerve. For instance, in November 2022, the Centers for Disease Control and Prevention, a US-based government agency for public health, reported that over 3 million Americans were grappling with glaucoma. Furthermore, it is anticipated that this figure will escalate to 6.3 million by 2050. Hence, the upswing in the incidence of eye disorders is fueling the growth of the optic nerve disorder treatment market.

The surge in the geriatric population is poised to be a driving force behind the expansion of the optic nerve disorder treatment market in the foreseeable future. This demographic encompasses elderly individuals, typically aged 65 and above. Within this group, optic nerve disorders emerge as a prevalent cause of vision impairment. Optic nerve disorder treatments play a crucial role in addressing the specific needs of this aging population, aiming to enhance vision, improve overall quality of life, and alleviate associated symptoms. For instance, a report released by the World Health Organization (WHO) in October 2022 highlighted that by the year 2030, one out of every six individuals worldwide is projected to be 60 years or older. Looking further ahead, by 2050, the global population of individuals aged 60 and above is expected to reach a staggering 2.1 billion. Furthermore, the number of individuals aged 80 years or older is set to increase by 426 million between 2020 and 2050, compared to current figures. Hence, the rising geriatric population stands as a pivotal factor driving the growth of the optic nerve disorder treatment market.

The anticipated high treatment costs are poised to impede the growth of the optic nerve disorder treatment market in the foreseeable future. The expenses associated with treating optic nerve disorders can be substantial, presenting a significant barrier for patients in accessing the necessary care. For instance, in April 2022, a report from Clinicspot, a healthcare company based in India, revealed that in India, the typical cost range for glaucoma surgery spans from $3.6 to $950 (Rs. 3000 to Rs. 75,000), contingent on various individualized factors. Consequently, the exorbitant treatment expenses represent a formidable hurdle for the optic nerve disorder treatment market.

Prominent players in the optic nerve disorder treatment market are strategically introducing innovative generic products to fortify their market position. A generic drug is one that is not branded but shares similarity in dosage, administration, and performance with a branded or reference-listed drug. For instance, in March 2021, Teva Pharmaceuticals USA Inc., a US-based pharmaceutical company, announced its FDA approval for the first generic version of AZOPT (brinzolamide ophthalmic suspension) 1%. This approval from the United States Food and Drug Administration (FDA), a federal agency, marked a significant milestone. Brinzolamide ophthalmic suspension 1% is a prescription drug designed to address elevated eye pressure in individuals with ocular hypertension or open-angle glaucoma, achieved by reducing the quantity of fluid within the eye.

In March 2021, Horizon Therapeutics PLC, a US-based biotechnology company, completed the acquisition of Viela Bio Inc. for a total of $3 billion. This strategic move is intended to bolster Horizon's research and clinical development capacities, augment its mid-stage biologics pipeline, and enhance its profound scientific expertise in autoimmune and severe inflammatory diseases. Viela Bio Inc., a clinical-stage biotechnology company based in the US, specializes in the development of therapies and medications for individuals grappling with autoimmune and severe inflammatory conditions, including those that impact the optic nerve.

Major players in the optic nerve disorders treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Sun Pharmaceutical Industries Limited, Bausch + Lomb Corporation, Horizon Therapeutics Inc., Santen Pharmaceutical Co. Ltd., Allergan Inc., Akorn Inc., Ionis Pharmaceuticals Inc., Lumenis Ltd., Glaukos Corporation, Nidek Co. Ltd., Aerie Pharmaceuticals Inc., Spark Therapeutics Inc., IRIDEX Corporation, Kowa Company Limited, New World Medical Inc., Heidelberg Engineering GmbH, Editas Medicine Inc., Quark Pharmaceuticals Inc., iSTAR Medical SA, Neurotech Pharmaceuticals Inc., Nicox SA., GenSight Biologics S.A., Inotek Pharmaceuticals Co., Oculis Holding AG .

North America was the largest region in the optic nerve disorders treatment market in 2023. The regions covered in optic nerve disorders treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the optic nerve disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The optic nerve disorders treatment market consists of revenues earned by entities through surgical interventions, plasma exchange therapy and gene therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The optic nerve disorders treatment market also includes sales of corticosteroids, antibiotics and vitamin supplements that are used in providing optic nerve disorders treatment services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Optic Nerve Disorders Treatment Market Characteristics

3. Optic Nerve Disorders Treatment Market Trends And Strategies

4. Optic Nerve Disorders Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Optic Nerve Disorders Treatment Market Size and Growth

  • 5.1. Global Optic Nerve Disorders Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Optic Nerve Disorders Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Optic Nerve Disorders Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Optic Nerve Disorders Treatment Market Segmentation

  • 6.1. Global Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Steroidal Therapy
  • Immunomodulators therapy
  • Other Treatment Types
  • 6.2. Global Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Glaucoma
  • Optic Neuritis
  • Optic Neuropathy
  • Congenital Optic Atrophy
  • Other Indications
  • 6.3. Global Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics
  • Other End Users

7. Optic Nerve Disorders Treatment Market Regional And Country Analysis

  • 7.1. Global Optic Nerve Disorders Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Optic Nerve Disorders Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Optic Nerve Disorders Treatment Market

  • 8.1. Asia-Pacific Optic Nerve Disorders Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Optic Nerve Disorders Treatment Market

  • 9.1. China Optic Nerve Disorders Treatment Market Overview
  • 9.2. China Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Optic Nerve Disorders Treatment Market

  • 10.1. India Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Optic Nerve Disorders Treatment Market

  • 11.1. Japan Optic Nerve Disorders Treatment Market Overview
  • 11.2. Japan Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Optic Nerve Disorders Treatment Market

  • 12.1. Australia Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Optic Nerve Disorders Treatment Market

  • 13.1. Indonesia Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Optic Nerve Disorders Treatment Market

  • 14.1. South Korea Optic Nerve Disorders Treatment Market Overview
  • 14.2. South Korea Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Optic Nerve Disorders Treatment Market

  • 15.1. Western Europe Optic Nerve Disorders Treatment Market Overview
  • 15.2. Western Europe Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Optic Nerve Disorders Treatment Market

  • 16.1. UK Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Optic Nerve Disorders Treatment Market

  • 17.1. Germany Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Optic Nerve Disorders Treatment Market

  • 18.1. France Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Optic Nerve Disorders Treatment Market

  • 19.1. Italy Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Optic Nerve Disorders Treatment Market

  • 20.1. Spain Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Optic Nerve Disorders Treatment Market

  • 21.1. Eastern Europe Optic Nerve Disorders Treatment Market Overview
  • 21.2. Eastern Europe Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Optic Nerve Disorders Treatment Market

  • 22.1. Russia Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Optic Nerve Disorders Treatment Market

  • 23.1. North America Optic Nerve Disorders Treatment Market Overview
  • 23.2. North America Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Optic Nerve Disorders Treatment Market

  • 24.1. USA Optic Nerve Disorders Treatment Market Overview
  • 24.2. USA Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Optic Nerve Disorders Treatment Market

  • 25.1. Canada Optic Nerve Disorders Treatment Market Overview
  • 25.2. Canada Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Optic Nerve Disorders Treatment Market

  • 26.1. South America Optic Nerve Disorders Treatment Market Overview
  • 26.2. South America Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Optic Nerve Disorders Treatment Market

  • 27.1. Brazil Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Optic Nerve Disorders Treatment Market

  • 28.1. Middle East Optic Nerve Disorders Treatment Market Overview
  • 28.2. Middle East Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Optic Nerve Disorders Treatment Market

  • 29.1. Africa Optic Nerve Disorders Treatment Market Overview
  • 29.2. Africa Optic Nerve Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Optic Nerve Disorders Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Optic Nerve Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Optic Nerve Disorders Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Optic Nerve Disorders Treatment Market Competitive Landscape
  • 30.2. Optic Nerve Disorders Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck and Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Regeneron Pharmaceuticals Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Optic Nerve Disorders Treatment Market Other Major And Innovative Companies

  • 31.1. Alcon Inc.
  • 31.2. Sun Pharmaceutical Industries Limited
  • 31.3. Bausch + Lomb Corporation
  • 31.4. Horizon Therapeutics Inc.
  • 31.5. Santen Pharmaceutical Co. Ltd.
  • 31.6. Allergan Inc.
  • 31.7. Akorn Inc.
  • 31.8. Ionis Pharmaceuticals Inc.
  • 31.9. Lumenis Ltd.
  • 31.10. Glaukos Corporation
  • 31.11. Nidek Co. Ltd.
  • 31.12. Aerie Pharmaceuticals Inc.
  • 31.13. Spark Therapeutics Inc.
  • 31.14. IRIDEX Corporation
  • 31.15. Kowa Company Limited

32. Global Optic Nerve Disorders Treatment Market Competitive Benchmarking

33. Global Optic Nerve Disorders Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Optic Nerve Disorders Treatment Market

35. Optic Nerve Disorders Treatment Market Future Outlook and Potential Analysis

  • 35.1 Optic Nerve Disorders Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Optic Nerve Disorders Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Optic Nerve Disorders Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer